BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 21, 2008
View Archived Issues
Imiquimod with PTD or HPV vaccination tested for vulval intraepithelial neoplasia
Read More
New agents for cardiovascular disorders disclosed in recent patents
Read More
Novel agents for respiratory disorders claimed in recent patent literature
Read More
Recent GSK patent divulges new antipsychotic agents
Read More
Immune stimulatory antigen-loaded particles show promise as tumor vaccine strategy
Read More
Infinity initiates phase I clinical trial of hedgehog pathway inhibitor IPI-926
Read More
Ipsen completes acquisition of Tercica
Read More
Miraculins enters into license agreement with Mount Sinai Hospital
Read More
Philips and Celsion enter research agreement to develop new cancer treatment
Read More
Lpath initiates dosing in phase I clinical trial of iSONEP in AMD
Read More
Ardea initiates combination phase I/II study of RDEA-119 and Nexavar in advanced cancer
Read More
Ono acquires from Progenics exclusive Japanese rights to Relistor
Read More
Crucell and Aeras initiate phase I and II trials in Africa of AERAS-402 TB vaccine
Read More
Novo Nordisk reports results from LEAD phase IIIb study of liraglutide in type 2 diabetes
Read More
Patients enter phase I combination study of GRN-163L for multiple myeloma
Read More
Positive final phase II results for EndoTAG-1 in pancreatic cancer
Read More
Aridol approved in Switzerland
Read More
VX-770 results show improvements in FEV1 and CFTR protein function
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Arena Pharmaceuticals
Read More
AstraZeneca submits Seroquel XR in Europe for generalized anxiety disorder
Read More
Basilea's Toctino approved in France for hand eczema
Read More
CeNeRx initiates phase II Tyrima trial in depression
Read More
New in vivo studies planned for RhuDex
Read More
Studies show anesthetic effect of PF-0713, evaluate mechanism of action
Read More
PYY-3-36 analogue AC-163954 demonstrates improved stability, antiobesity effects in rodents
Read More
